MB Diagnostics ApS: Financial statements 2020
CVR: 38185853
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -8,625 and a net result of DKK -20,019 compared with DKK 447,892 the year before. Equity in the 2020 report amounted to DKK 806,537. The solvency ratio was 68.8%.
- Gross Profit
- DKK -8,625
- Profit/Loss
- DKK -20,019
- Equity
- DKK 806,537
- Total Assets
- DKK 1,172,046
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -9 t. | -20 t. | 807 t. | 0 |
| 2019 | - | 586 t. | 448 t. | 827 t. | 0 |
| 2018 | - | 645 t. | 491 t. | 379 t. | 0 |
How creditworthy is MB Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
MB Diagnostics ApS has published its annual report for 2019. Gross profit came to DKK 585,836, and the net result was DKK 447,892.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.